Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea

BACKGROUND: To evaluate efficacy in patients with brain metastasis (BM) on entry into the lapatinib expanded access program (LEAP). METHODS: LEAP is a worldwide, single-arm, open-label study. HER2-positive, locally-advanced or metastatic breast cancer patients with progression after an anthracycline...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ro, Jungsil, Park, Sohee, Kim, Sung- Bae, Kim, Tae You, Im, Young Hyuk, Rha, Sun Young, Chung, Joo Seop, Moon, Hanlim, Santillana, Sergio
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3480888/
https://ncbi.nlm.nih.gov/pubmed/22839200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-322
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados